← Back to news

Medtronic gets CE mark for ablation to treat ventricular tachycardia

MedTech Dive ยท August 7, 2026

Medtronic received CE mark approval for a new ablation treatment addressing ventricular tachycardia, a life-threatening heart condition. The company indicates the approach is more effective than older ablation methods for this condition.

Read the full article on MedTech Dive